Evaluation of Candidate Therapeutics in Mouse Models of Orthopoxviruses
$571,586Y01FY2020AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
The primary goal of this interagency agreement is to identify and develop small molecule inhibitors targeting orthopoxviruses.
View original record on NIH RePORTER →